17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

Molecular and Cellular Endocrinology

Volumn 315, Issue 1-2, 2010, Pages 74-80

  Jiang, Xiaohong ^a   Zhang, Yan ^a   Hou, Dongxia ^a   Zhu, Lingyun ^a   Xu, Wei ^a   Ding, Li ^a   Qi, Xiaoqiang ^a   Sun, Guoxun ^a   Liu, Chang ^a   Zhang, Junfeng ^a   Zen, Ke ^a   Xiang, Yang ^a   Zhang, Chen Yu ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

17 Estradiol; Atherosclerosis; Oleic acid; PGC 1 ; VSMC

Indexed keywords

ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SMALL INTERFERING RNA; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; PPARGC1A PROTEIN, RAT; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME PHOSPHORYLATION; INHIBITION KINETICS; MALE; MOLECULAR MECHANICS; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLEIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 71849116919     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.09.018     Document Type: Article

References (56)

1. Barchiesi F., Jackson E.K., et al. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs. Hypertension 39 4 (2002) 874-879
2. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95 1 (1997) 252-264
3. Chu B.Y., Tran K., et al. Regulation of ERK1 gene expression by coactivator proteins. Biochem. J. 392 Pt 3 (2005) 589-599
4. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 86 9 (2000) 943-949
5. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268 20 (1993) 14553-14556
6. Dubey R.K., Jackson E.K., et al. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler. Thromb. Vasc. Biol. 20 4 (2000) 964-972
7. Dzau V.J., Braun-Dullaeus R.C., et al. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8 11 (2002) 1249-1256
8. Eferakeya A.E., and Imasuen J.E. Relationship of menopause to serum cholesterol and arterial blood pressure in some Nigerian women. Public Health 100 1 (1986) 28-32
9. Ekshyyan V.P., Hebert V.Y., et al. Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production. J. Cardiovasc. Pharmacol. 50 1 (2007) 83-93
10. Esterbauer H., Oberkofler H., et al. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 62 1 (1999) 98-102
11. Glass C.K. Going nuclear in metabolic and cardiovascular disease. J. Clin. Invest. 116 3 (2006) 556-560
12. Gordon D., Mohai L.G., et al. Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ. Res. 59 6 (1986) 633-644
13. Grady D., Rubin S.M., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117 12 (1992) 1016-1037
14. Grodstein F., Stampfer M.J., et al. Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336 25 (1997) 1769-1775
15. Grotendorst G.R., Seppa H.E., et al. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 78 6 (1981) 3669-3672
16. Herynk M.H., and Fuqua S.A. Estrogen receptor mutations in human disease. Endocr. Rev. 25 6 (2004) 869-898
17. Hondares E., Mora O., et al. Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation. Endocrinology 147 6 (2006) 2829-2838
18. Hsieh Y.C., Yang S., et al. Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1. Am. J. Physiol. Heart Circ. Physiol. 290 1 (2006) H416-H423
19. Hsieh Y.C., Yang S., et al. PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage. Am. J. Physiol. Heart Circ. Physiol. 289 6 (2005) H2665-H2672
20. Karas R.H., Patterson B.L., et al. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89 5 (1994) 1943-1950
21. Knutti D., Kaul A., et al. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol. Cell. Biol. 20 7 (2000) 2411-2422
22. Larrouy D., Vidal H., et al. Cloning and mRNA tissue distribution of human PPARgamma coactivator-1. Int. J. Obes. Relat. Metab. Disord. 23 12 (1999) 1327-1332
23. Laufs U., Adam O., et al. Down-regulation of Rac-1 GTPase by estrogen. J. Biol. Chem. 278 8 (2003) 5956-5962
24. Lee H.J., Su Y., et al. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1alpha) upregulated E-cadherin expression in HepG2 cells. FEBS Lett. 582 5 (2008) 627-634
25. Leung K.C., Johannsson G., et al. Estrogen regulation of growth hormone action. Endocr. Rev. 25 5 (2004) 693-721
26. Liang H., and Ward W.F. PGC-1alpha: a key regulator of energy metabolism. Adv. Physiol. Educ. 30 4 (2006) 145-151
27. Ling S., Dai A., et al. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse. Circulation 109 4 (2004) 537-543
28. Ling S., Deng G., et al. Estrogen inhibits mechanical strain-induced mitogenesis in human vascular smooth muscle cells via down-regulation of Sp-1. Cardiovasc. Res. 50 1 (2001) 108-114
29. Lu G., Meier K.E., et al. Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells. Hypertension 31 4 (1998) 978-985
30. Majack R.A., and Clowes A.W. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell Physiol. 118 3 (1984) 253-256
31. Marshall N.J., Goodwin C.J., et al. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 5 2 (1995) 69-84
32. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 23 (1999) 1801-1811
33. Morey A.K., Pedram A., et al. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138 8 (1997) 3330-3339
34. Mosselman S., Polman J., et al. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392 1 (1996) 49-53
35. Musgrove E.A., Sergio C.M., et al. Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS One 3 8 (2008) e2987
36. Nickenig G., Baumer A.T., et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97 22 (1998) 2197-2201
37. Oda N., Abe M., et al. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J. Cell Physiol. 178 2 (1999) 121-132
38. Puigserver P., Wu Z., et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 6 (1998) 829-839
39. Rogers P.A., and Abberton K.M. Endometrial arteriogenesis: vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders. Microsc. Res. Tech. 60 4 (2003) 412-419
40. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 6423 (1993) 801-809
41. Sarkar R., Meinberg E.G., et al. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78 2 (1996) 225-230
42. Schreiber S.N., Knutti D., et al. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278 11 (2003) 9013-9018
43. Stampfer M.J., Colditz G.A., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N. Engl. J. Med. 325 11 (1991) 756-762
44. Sullivan Jr. T.R., Karas R.H., et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J. Clin. Invest. 96 5 (1995) 2482-2488
45. Suzuki A., Mizuno K., et al. Effects of 17 beta-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc. Res. 32 3 (1996) 516-523
46. Tcherepanova I., Puigserver P., et al. Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1. J. Biol. Chem. 275 21 (2000) 16302-16308
47. Tsutsumi S., Zhang X., et al. Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. J. Endocrinol. 199 2 (2008) 267-273
48. Tulis D.A. Methods for identifying cardiovascular agents: a review. Recent Pat. Cardiovasc. Drug Discov. 1 1 (2006) 47-56
49. Vargas R., Wroblewska B., et al. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br. J. Pharmacol. 109 3 (1993) 612-617
50. Vega R.B., Huss J.M., et al. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20 5 (2000) 1868-1876
51. Wu Z., Puigserver P., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 1 (1999) 115-124
52. Yang S.H., and Sharrocks A.D. Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1. Biochem. Soc. Symp. 73 (2006) 121-129
53. Yoon J.C., Puigserver P., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 6852 (2001) 131-138
54. Yun M.R., Lee J.Y., et al. Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/Akt signaling pathway. Pharmacol. Res. 54 2 (2006) 97-102
55. Zhang H.M., Li L., et al. Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1. Nucleic Acids Res. 36 8 (2008) 2594-2607
56. Zhang Y., Liu C., et al. PGC-1alpha inhibits oleic acid induced proliferation and migration of rat vascular smooth muscle cells. PLoS One 2 11 (2007) e1137